mva-bn-rsv
Vaccineexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02419391)
Timeline
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva-bn-rsv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05238025 | Phase 3 | Apr 19, 2022 | Bavarian Nordic |
| NCT02864628 | Phase 1 | Sep 1, 2016 | Bavarian Nordic, Johnson County Clin-Trials |
| NCT02873286 | Phase 2 | Sep 1, 2016 | Bavarian Nordic, Washington University in St. Louis |
| NCT02419391 | Phase 1 | Aug 1, 2015 | Bavarian Nordic, Johnson County Clin-Trials |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bavarian Nordic | For profit | 4 | 4 | 3 | 2015 |
| Johnson County Clin-Trials | For profit | 2 | 0 | 1 | 2015 |
| Washington University in St. Louis | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1